Promotion at Poland's Selvita

The Supervisory Board of Selvita (PL: SLV), Poland’s largest biotech firm, has appointed Edyta Jaworska to the position of a management board member, responsible for the development of its integrated drug discovery services.

Mrs Jaworska joined Selvita in 2012, starting as a business development manager responsible for the sales and development of Selvita offer in selected Western European countries. In 2014, she was promoted to the position of business development director, taking over management of a sales team responsible for sales and development of Selvita services offer in Western Europe, Israel and Japan.

“As part of our continued corporate growth initiatives in the drug discovery services business segment we decided to strengthen our management board with Edyta, who has always excelled in her previous roles at Selvita and is responsible for the development of our integrated service activities,” commented Pawel Przewiezlikowski, chief executive at Selvita.